India · Delayed Price · Currency is INR Dr. Lal PathLabs Statistics
Total Valuation
NSE:LALPATHLAB has a market cap or net worth of INR 337.22 billion. The enterprise value is 323.83 billion.
| Market Cap | 337.22B |
| Enterprise Value | 323.83B |
Important Dates
The last earnings date was Wednesday, November 4, 2026.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Nov 11, 2026 |
Share Statistics
NSE:LALPATHLAB has 167.27 million shares outstanding. The number of shares has increased by 0.34% in one year.
| Current Share Class | 167.27M |
| Shares Outstanding | 167.27M |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 54.31% |
| Owned by Institutions (%) | 34.61% |
| Float | 75.97M |
Valuation Ratios
The trailing PE ratio is 57.81 and the forward PE ratio is 46.20. NSE:LALPATHLAB's PEG ratio is 2.41.
| PE Ratio | 57.81 |
| Forward PE | 46.20 |
| PS Ratio | 11.11 |
| PB Ratio | 12.13 |
| P/TBV Ratio | 16.96 |
| P/FCF Ratio | 52.58 |
| P/OCF Ratio | 47.24 |
| PEG Ratio | 2.41 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.31, with an EV/FCF ratio of 50.50.
| EV / Earnings | 55.50 |
| EV / Sales | 10.67 |
| EV / EBITDA | 36.31 |
| EV / EBIT | 44.93 |
| EV / FCF | 50.50 |
Financial Position
The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.86 |
| Quick Ratio | 3.58 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | 0.36 |
| Interest Coverage | 27.10 |
Financial Efficiency
Return on equity (ROE) is 22.61% and return on invested capital (ROIC) is 38.92%.
| Return on Equity (ROE) | 22.61% |
| Return on Assets (ROA) | 14.04% |
| Return on Invested Capital (ROIC) | 38.92% |
| Return on Capital Employed (ROCE) | 24.27% |
| Weighted Average Cost of Capital (WACC) | 5.37% |
| Revenue Per Employee | 5.83M |
| Profits Per Employee | 1.12M |
| Employee Count | 5,206 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 22.24 |
Taxes
In the past 12 months, NSE:LALPATHLAB has paid 1.86 billion in taxes.
| Income Tax | 1.86B |
| Effective Tax Rate | 24.00% |
Stock Price Statistics
The stock price has increased by +31.59% in the last 52 weeks. The beta is 0.20, so NSE:LALPATHLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +31.59% |
| 50-Day Moving Average | 1,926.74 |
| 200-Day Moving Average | 1,663.42 |
| Relative Strength Index (RSI) | 59.46 |
| Average Volume (20 Days) | 307,908 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:LALPATHLAB had revenue of INR 30.34 billion and earned 5.83 billion in profits. Earnings per share was 34.88.
| Revenue | 30.34B |
| Gross Profit | 18.48B |
| Operating Income | 7.21B |
| Pretax Income | 7.74B |
| Net Income | 5.83B |
| EBITDA | 8.52B |
| EBIT | 7.21B |
| Earnings Per Share (EPS) | 34.88 |
Balance Sheet
The company has 16.07 billion in cash and 2.33 billion in debt, with a net cash position of 13.74 billion or 82.11 per share.
| Cash & Cash Equivalents | 16.07B |
| Total Debt | 2.33B |
| Net Cash | 13.74B |
| Net Cash Per Share | 82.11 |
| Equity (Book Value) | 27.80B |
| Book Value Per Share | 164.36 |
| Working Capital | 13.95B |
Cash Flow
In the last 12 months, operating cash flow was 7.14 billion and capital expenditures -725.20 million, giving a free cash flow of 6.41 billion.
| Operating Cash Flow | 7.14B |
| Capital Expenditures | -725.20M |
| Depreciation & Amortization | 1.31B |
| Net Borrowing | -380.55M |
| Free Cash Flow | 6.41B |
| FCF Per Share | 38.34 |
Margins
Gross margin is 60.92%, with operating and profit margins of 23.76% and 19.23%.
| Gross Margin | 60.92% |
| Operating Margin | 23.76% |
| Pretax Margin | 25.50% |
| Profit Margin | 19.23% |
| EBITDA Margin | 28.07% |
| EBIT Margin | 23.76% |
| FCF Margin | 21.14% |
Dividends & Yields
This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 0.99%.
| Dividend Per Share | 20.00 |
| Dividend Yield | 0.99% |
| Dividend Growth (YoY) | 40.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 45.52% |
| FCF Payout Ratio | 45.65% |
| Buyback Yield | -0.34% |
| Shareholder Yield | 0.65% |
| Earnings Yield | 1.73% |
| FCF Yield | 1.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:LALPATHLAB is 2,210.15, which is 9.63% higher than the current price. The consensus rating is "Buy".
| Price Target | 2,210.15 |
| Price Target Difference | 9.63% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 15.52% |
| EPS Growth Forecast (3Y) | 20.47% |
Stock Splits
The last stock split was on December 19, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Dec 19, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |